跳至主要内容
临床试验/RPCEC00000441
RPCEC00000441尚未招募1 期

Effect of the probiotic supplement EDC-HHA01 (OptiBiotics Plus) in the treatment of Type 2 Diabetes Mellitus.

Hermanos Ameijeiras Clinical Surgical Hospital0 个研究点目标入组 100 人开始时间: 2024年5月30日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
19 years 至 one(—)
性别
All

入选标准

  • 1- Type 2 diabetic and prediabetic individuals from all over the country who attend the specialized consultations of the Hermanos Ameijeiras Hospital, over 18 years of age, without distinction of sex or skin color and who give their consent to participate in the study
  • 2-Diabetic individuals who only have oral antihyperglycemic treatments.
  • 3- Do not ingest probiotics at the time of study recruitment.

排除标准

  • 1- Type 2 diabetic individuals with insulin treatment.
  • 2-Individuals with type 1 or other Diabetes.
  • 3- Medical alterations that could simulate the symptoms of Type 2 Diabetes Mellitus (T2DM)
  • 4-Active or uncontrolled co-morbidities (including depression, untreated endocrine diagnosis, recent acute infection), which in the physician's opinion could interfere with the patient's ability to participate in the study.
  • 5-Pregnancy or breastfeeding period.
  • 6-Kidney failure or evidence of substance abuse.
  • 7-Participate in other clinical treatments or improvement of symptoms as a result of treatment interventions three months previously

研究者

发起方
Hermanos Ameijeiras Clinical Surgical Hospital

相似试验

Effect of the probiotic supplement EDC-HHA01... | 临床试验